Mozart Therapeutics is a clinical-stage biopharmaceutical company committed to developing disease-modifying therapies that restore healthy immune system function in patients with autoimmune disease. Our first-in-class CD8 Treg modulators target a fundamental cause of immune surveillance dysregulation to restore durable immune homeostasis across autoimmune disorders.